| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,689 |
36,162 |
$4.08M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,977 |
38,310 |
$4.00M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
41,798 |
38,951 |
$3.52M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,962 |
18,836 |
$2.61M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,522 |
16,466 |
$2.13M |
| J9271 |
Injection, pembrolizumab, 1 mg |
124 |
95 |
$1.62M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
18,648 |
6,292 |
$1.46M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,344 |
5,693 |
$1.43M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
5,041 |
1,753 |
$1.32M |
| 80053 |
Comprehensive metabolic panel |
66,432 |
60,365 |
$1.11M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,840 |
4,754 |
$1.06M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
794 |
754 |
$1.01M |
| 90834 |
Psychotherapy, 45 minutes with patient |
6,701 |
3,981 |
$920K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,981 |
3,065 |
$885K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
34,575 |
32,259 |
$858K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,161 |
5,961 |
$723K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,994 |
2,918 |
$690K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,459 |
3,391 |
$676K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,910 |
1,879 |
$668K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,682 |
5,506 |
$655K |
| 90839 |
|
3,941 |
3,631 |
$569K |
| 93975 |
|
2,223 |
2,190 |
$511K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,481 |
2,138 |
$511K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,749 |
3,740 |
$489K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,742 |
3,727 |
$453K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,463 |
2,204 |
$416K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,589 |
1,570 |
$378K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
2,880 |
2,857 |
$362K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
7,208 |
6,703 |
$332K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
9,982 |
9,936 |
$325K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,124 |
3,035 |
$314K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12,007 |
11,798 |
$260K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
4,171 |
1,049 |
$255K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12,018 |
11,807 |
$250K |
| 96415 |
|
462 |
390 |
$249K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13,672 |
12,233 |
$248K |
| 84443 |
Thyroid stimulating hormone (TSH) |
29,415 |
28,910 |
$240K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,080 |
1,420 |
$223K |
| 36415 |
Collection of venous blood by venipuncture |
50,410 |
37,253 |
$218K |
| 97161 |
|
2,304 |
2,262 |
$217K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
847 |
838 |
$214K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
6,608 |
6,604 |
$199K |
| 99215 |
Prolong outpt/office vis |
1,580 |
1,461 |
$194K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
747 |
741 |
$181K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
127 |
127 |
$180K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,467 |
1,732 |
$177K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,920 |
2,918 |
$175K |
| 80061 |
Lipid panel |
24,805 |
24,652 |
$173K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18,578 |
18,452 |
$169K |
| 20610 |
|
671 |
616 |
$162K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
21,057 |
19,738 |
$153K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,261 |
4,181 |
$153K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
445 |
441 |
$144K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,885 |
3,812 |
$141K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
4,739 |
4,736 |
$141K |
| 97162 |
|
1,124 |
1,119 |
$139K |
| 93017 |
|
997 |
975 |
$138K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,065 |
1,063 |
$135K |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
74 |
63 |
$135K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
2,863 |
2,827 |
$134K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
54,714 |
48,573 |
$130K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
371 |
368 |
$122K |
| 84439 |
|
12,801 |
12,638 |
$121K |
| 99243 |
|
993 |
988 |
$120K |
| 86850 |
|
4,316 |
4,012 |
$119K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,356 |
2,320 |
$119K |
| G0378 |
Hospital observation service, per hour |
1,539 |
1,492 |
$116K |
| 92567 |
|
1,799 |
1,765 |
$115K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
702 |
701 |
$110K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
3,481 |
3,378 |
$110K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
850 |
848 |
$109K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,958 |
5,920 |
$106K |
| 92557 |
|
1,859 |
1,853 |
$105K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,119 |
1,782 |
$103K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
870 |
868 |
$103K |
| 82607 |
|
8,442 |
8,366 |
$103K |
| 93971 |
|
1,726 |
1,686 |
$101K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,413 |
6,230 |
$100K |
| 12001 |
|
256 |
254 |
$99K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
13,477 |
12,714 |
$98K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
721 |
601 |
$93K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,238 |
1,224 |
$91K |
| 90791 |
Psychiatric diagnostic evaluation |
516 |
491 |
$87K |
| 93226 |
|
542 |
535 |
$86K |
| 85027 |
|
22,227 |
20,685 |
$83K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,836 |
2,519 |
$83K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
986 |
937 |
$81K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
202 |
202 |
$81K |
| 76775 |
|
1,765 |
1,733 |
$79K |
| 86618 |
|
3,782 |
3,651 |
$75K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,131 |
529 |
$75K |
| 82728 |
|
6,320 |
6,194 |
$74K |
| 86901 |
|
4,615 |
4,209 |
$73K |
| 93970 |
|
209 |
206 |
$72K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
589 |
587 |
$72K |
| 92592 |
|
967 |
836 |
$70K |
| 92593 |
|
821 |
727 |
$68K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,826 |
1,782 |
$67K |
| 99408 |
|
1,602 |
1,558 |
$65K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
91 |
59 |
$64K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,991 |
1,961 |
$64K |
| 86780 |
|
4,977 |
4,924 |
$64K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,324 |
1,845 |
$62K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
311 |
260 |
$61K |
| 87563 |
|
2,489 |
2,472 |
$59K |
| 86900 |
|
4,617 |
4,212 |
$59K |
| 87077 |
|
6,685 |
6,453 |
$58K |
| 47562 |
|
24 |
24 |
$58K |
| 86803 |
|
5,613 |
5,591 |
$57K |
| 84153 |
|
3,118 |
3,098 |
$55K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,589 |
3,543 |
$54K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
471 |
134 |
$49K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,101 |
2,050 |
$49K |
| 97166 |
|
401 |
399 |
$46K |
| 90837 |
Psychotherapy, 53 minutes with patient |
338 |
242 |
$44K |
| 83970 |
|
1,072 |
1,049 |
$44K |
| 84702 |
|
4,400 |
3,355 |
$44K |
| 99233 |
Prolong inpt eval add15 m |
448 |
235 |
$43K |
| 84403 |
|
1,647 |
1,618 |
$43K |
| 82746 |
|
3,619 |
3,592 |
$41K |
| 71250 |
|
448 |
445 |
$41K |
| 73221 |
|
174 |
170 |
$41K |
| 93225 |
|
270 |
270 |
$40K |
| 99442 |
|
1,032 |
998 |
$39K |
| 69210 |
|
795 |
774 |
$38K |
| 58661 |
|
24 |
24 |
$38K |
| 76830 |
Ultrasound, transvaginal |
1,671 |
1,649 |
$37K |
| 83880 |
|
1,123 |
1,090 |
$36K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
55 |
54 |
$36K |
| 31231 |
|
278 |
276 |
$36K |
| 83655 |
|
2,477 |
2,459 |
$35K |
| 99406 |
|
1,134 |
1,105 |
$34K |
| 71271 |
|
1,103 |
1,103 |
$34K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
365 |
363 |
$34K |
| 87522 |
Neg quan hep c or qual rna |
690 |
661 |
$33K |
| 77065 |
Tomosynthesis, mammo |
467 |
457 |
$33K |
| 90715 |
|
1,167 |
1,162 |
$33K |
| 86762 |
|
2,075 |
2,060 |
$32K |
| 99173 |
|
612 |
610 |
$31K |
| 90686 |
|
1,124 |
1,121 |
$31K |
| 30140 |
|
14 |
14 |
$31K |
| 94060 |
|
201 |
199 |
$30K |
| 88304 |
|
1,264 |
1,260 |
$30K |
| 76536 |
|
1,364 |
1,354 |
$30K |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
275 |
252 |
$29K |
| 87340 |
|
2,647 |
2,629 |
$28K |
| 85610 |
|
7,016 |
5,231 |
$28K |
| 86140 |
|
7,852 |
7,210 |
$28K |
| 83540 |
|
6,043 |
5,926 |
$28K |
| S5161 |
Emergency response system; service fee, per month (excludes installation and testing) |
818 |
815 |
$27K |
| 70486 |
|
449 |
448 |
$27K |
| 86617 |
|
1,021 |
1,005 |
$27K |
| 83001 |
|
1,306 |
1,288 |
$26K |
| 76642 |
|
1,415 |
1,408 |
$26K |
| 86769 |
|
726 |
400 |
$26K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,006 |
988 |
$26K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
918 |
380 |
$26K |
| 84146 |
|
1,362 |
1,339 |
$25K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,519 |
2,517 |
$25K |
| 88342 |
|
508 |
504 |
$25K |
| 71046 |
Radiologic examination, chest; 2 views |
5,474 |
5,383 |
$25K |
| 83735 |
|
11,460 |
10,221 |
$24K |
| 82784 |
|
1,773 |
1,731 |
$24K |
| 84402 |
|
949 |
937 |
$24K |
| 97113 |
|
242 |
94 |
$24K |
| 87186 |
|
3,807 |
3,696 |
$22K |
| 86787 |
|
1,836 |
1,805 |
$22K |
| 92551 |
|
325 |
323 |
$22K |
| 82670 |
|
746 |
720 |
$21K |
| 88307 |
|
281 |
277 |
$21K |
| 83550 |
|
4,868 |
4,791 |
$20K |
| J1756 |
Injection, iron sucrose, 1 mg |
337 |
158 |
$20K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,956 |
1,852 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
514 |
510 |
$20K |
| 87653 |
|
798 |
788 |
$19K |
| 99245 |
|
137 |
136 |
$18K |
| 82043 |
|
3,425 |
3,404 |
$17K |
| 86038 |
|
3,100 |
3,064 |
$17K |
| 83002 |
|
906 |
887 |
$16K |
| 86480 |
|
294 |
291 |
$16K |
| 87468 |
|
622 |
612 |
$16K |
| 99223 |
Prolong inpt eval add15 m |
96 |
94 |
$16K |
| 85651 |
|
7,428 |
7,041 |
$16K |
| 81001 |
|
9,699 |
9,058 |
$16K |
| 87529 |
|
418 |
410 |
$15K |
| 86235 |
|
741 |
724 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,802 |
16,863 |
$15K |
| 84481 |
|
1,503 |
1,484 |
$14K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
817 |
795 |
$14K |
| 86376 |
|
851 |
841 |
$14K |
| 12002 |
|
37 |
37 |
$14K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
24 |
24 |
$13K |
| 85007 |
|
5,428 |
4,821 |
$13K |
| 92550 |
|
163 |
163 |
$13K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
103 |
103 |
$13K |
| 82570 |
|
2,568 |
2,407 |
$13K |
| 96367 |
|
159 |
90 |
$13K |
| 76641 |
|
415 |
413 |
$13K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
113 |
113 |
$13K |
| 92587 |
|
324 |
322 |
$12K |
| 80076 |
|
1,116 |
1,097 |
$12K |
| 99443 |
|
353 |
328 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,368 |
2,298 |
$12K |
| 87484 |
|
612 |
603 |
$12K |
| 77080 |
|
197 |
197 |
$11K |
| 87070 |
|
1,855 |
1,810 |
$11K |
| 86665 |
|
358 |
357 |
$11K |
| 77066 |
Tomosynthesis, mammo |
183 |
183 |
$11K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,032 |
9,677 |
$11K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
82 |
54 |
$11K |
| 81025 |
|
3,387 |
3,276 |
$11K |
| 99205 |
Prolong outpt/office vis |
85 |
83 |
$11K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
62 |
62 |
$10K |
| 77061 |
|
174 |
174 |
$10K |
| 12011 |
|
28 |
28 |
$10K |
| 87469 |
|
514 |
508 |
$10K |
| 93298 |
|
444 |
444 |
$10K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
58 |
38 |
$9K |
| 77336 |
|
31 |
12 |
$9K |
| 86430 |
|
1,946 |
1,936 |
$9K |
| 83690 |
|
8,060 |
7,466 |
$9K |
| 84550 |
|
2,203 |
2,018 |
$9K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
25 |
25 |
$9K |
| 82550 |
|
2,336 |
2,203 |
$9K |
| 86160 |
|
440 |
425 |
$9K |
| 70496 |
|
39 |
39 |
$8K |
| 51798 |
|
24 |
24 |
$8K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
189 |
189 |
$8K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
2,482 |
2,395 |
$8K |
| 80050 |
General health panel |
332 |
330 |
$8K |
| 73630 |
|
1,898 |
1,763 |
$8K |
| 86706 |
|
854 |
848 |
$8K |
| 73030 |
|
1,811 |
1,708 |
$8K |
| 77062 |
|
104 |
104 |
$8K |
| 73564 |
|
1,645 |
1,566 |
$8K |
| 82803 |
|
293 |
268 |
$8K |
| 76801 |
|
76 |
74 |
$7K |
| 93297 |
|
428 |
427 |
$7K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
124 |
118 |
$7K |
| 82950 |
|
1,381 |
1,368 |
$7K |
| 94727 |
|
217 |
215 |
$7K |
| 86696 |
|
442 |
437 |
$7K |
| 86364 |
|
846 |
804 |
$7K |
| 86800 |
|
490 |
481 |
$7K |
| 84156 |
|
1,845 |
1,630 |
$7K |
| 76000 |
|
84 |
82 |
$7K |
| 70498 |
|
65 |
65 |
$7K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,295 |
928 |
$6K |
| 74018 |
|
1,230 |
1,194 |
$6K |
| 86666 |
|
349 |
343 |
$6K |
| 83615 |
|
3,447 |
2,927 |
$6K |
| 73610 |
|
1,864 |
1,723 |
$6K |
| 90840 |
|
49 |
49 |
$6K |
| 25600 |
|
12 |
12 |
$6K |
| 99441 |
|
199 |
190 |
$6K |
| 76870 |
|
373 |
369 |
$6K |
| 90734 |
|
192 |
191 |
$5K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
85 |
85 |
$5K |
| 84100 |
|
1,418 |
1,280 |
$5K |
| 81003 |
|
7,072 |
6,840 |
$5K |
| 82977 |
|
1,001 |
972 |
$5K |
| 85730 |
|
1,575 |
1,530 |
$5K |
| 73130 |
|
1,394 |
1,260 |
$5K |
| 70491 |
|
25 |
25 |
$5K |
| 73110 |
|
1,414 |
1,297 |
$5K |
| 72110 |
|
261 |
261 |
$5K |
| 86664 |
|
301 |
301 |
$4K |
| 87177 |
|
291 |
272 |
$4K |
| 82150 |
|
898 |
887 |
$4K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
23 |
12 |
$4K |
| 82947 |
|
563 |
512 |
$4K |
| 72100 |
|
696 |
695 |
$4K |
| 87046 |
|
346 |
345 |
$4K |
| 73502 |
|
806 |
785 |
$4K |
| 86663 |
|
303 |
303 |
$4K |
| 73562 |
|
562 |
534 |
$4K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
85 |
82 |
$4K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
15 |
15 |
$4K |
| 94729 |
|
181 |
179 |
$3K |
| 0012A |
|
134 |
134 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,463 |
2,347 |
$3K |
| 87641 |
|
94 |
93 |
$3K |
| 85379 |
|
1,524 |
1,503 |
$3K |
| 0002A |
|
80 |
80 |
$3K |
| 90651 |
|
77 |
75 |
$3K |
| 97022 |
|
135 |
51 |
$3K |
| 76770 |
|
44 |
44 |
$3K |
| 74246 |
|
13 |
13 |
$3K |
| 87045 |
|
345 |
344 |
$3K |
| 31575 |
|
61 |
58 |
$3K |
| 87209 |
|
282 |
260 |
$3K |
| 88341 |
|
112 |
112 |
$3K |
| 98929 |
|
45 |
41 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
43 |
42 |
$2K |
| 95886 |
|
26 |
26 |
$2K |
| 82105 |
|
347 |
344 |
$2K |
| 97597 |
|
44 |
28 |
$2K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
12 |
12 |
$2K |
| 87899 |
|
312 |
311 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,138 |
1,355 |
$2K |
| 93976 |
|
17 |
17 |
$2K |
| 0011A |
|
136 |
136 |
$2K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,385 |
1,356 |
$2K |
| 82948 |
|
4,662 |
2,983 |
$2K |
| 93923 |
|
12 |
12 |
$2K |
| 95816 |
|
13 |
12 |
$2K |
| 73100 |
|
660 |
485 |
$2K |
| 90619 |
|
47 |
47 |
$2K |
| 84165 |
|
310 |
304 |
$2K |
| 84460 |
|
480 |
471 |
$2K |
| 84484 |
|
5,454 |
4,292 |
$2K |
| 86765 |
|
132 |
126 |
$2K |
| 93296 |
|
110 |
110 |
$2K |
| 83516 |
|
229 |
165 |
$2K |
| 80074 |
|
58 |
58 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
364 |
298 |
$1K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
32 |
32 |
$1K |
| 86225 |
|
281 |
276 |
$1K |
| 84703 |
|
2,956 |
2,891 |
$1K |
| 90656 |
|
93 |
93 |
$1K |
| 0001A |
|
81 |
81 |
$1K |
| 73140 |
|
770 |
669 |
$1K |
| 86300 |
|
172 |
156 |
$1K |
| 90882 |
|
85 |
66 |
$1K |
| 83993 |
|
105 |
105 |
$1K |
| 86694 |
|
207 |
207 |
$1K |
| 85046 |
|
780 |
759 |
$1K |
| 97116 |
|
26 |
14 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,125 |
2,967 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,509 |
7,677 |
$1K |
| 71045 |
Radiologic examination, chest; single view |
5,458 |
5,242 |
$1K |
| 73080 |
|
423 |
389 |
$1K |
| 87040 |
|
1,290 |
840 |
$1K |
| 84450 |
|
271 |
264 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$1K |
| 86704 |
|
109 |
109 |
$1K |
| 80178 |
|
114 |
109 |
$958.54 |
| 84480 |
|
122 |
122 |
$927.59 |
| 86735 |
|
87 |
85 |
$901.66 |
| 86147 |
|
54 |
53 |
$892.59 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,229 |
811 |
$861.72 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
18 |
12 |
$845.90 |
| 88142 |
|
39 |
39 |
$834.05 |
| 83921 |
|
39 |
39 |
$746.95 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,486 |
7,813 |
$733.22 |
| 90677 |
|
14 |
14 |
$733.04 |
| 84425 |
|
52 |
49 |
$690.16 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12 |
12 |
$670.26 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,156 |
1,140 |
$660.30 |
| 73090 |
|
143 |
116 |
$600.46 |
| 82533 |
|
40 |
40 |
$584.13 |
| 86255 |
|
107 |
106 |
$582.28 |
| 82565 |
|
113 |
111 |
$567.12 |
| 72050 |
|
42 |
42 |
$554.80 |
| 86215 |
|
102 |
102 |
$554.72 |
| 90710 |
|
25 |
25 |
$547.76 |
| 90670 |
|
26 |
26 |
$543.34 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,987 |
1,960 |
$534.33 |
| 95806 |
|
79 |
79 |
$533.61 |
| 86756 |
|
185 |
182 |
$511.23 |
| G0008 |
Administration of influenza virus vaccine |
77 |
77 |
$480.15 |
| 86708 |
|
50 |
50 |
$468.44 |
| 73590 |
|
166 |
144 |
$457.77 |
| 80164 |
|
40 |
37 |
$422.43 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
25 |
25 |
$413.81 |
| 72040 |
|
53 |
53 |
$410.67 |
| 96523 |
|
12 |
12 |
$402.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,177 |
7,165 |
$397.54 |
| 86334 |
|
28 |
26 |
$395.69 |
| 82747 |
|
51 |
50 |
$388.59 |
| 83010 |
|
40 |
39 |
$375.99 |
| 83605 |
|
1,674 |
1,526 |
$375.30 |
| 83525 |
|
30 |
28 |
$369.79 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
339 |
321 |
$356.48 |
| V5266 |
Battery for use in hearing device |
924 |
884 |
$338.39 |
| 87338 |
|
43 |
42 |
$331.46 |
| 82785 |
|
26 |
24 |
$329.13 |
| 82627 |
|
13 |
13 |
$293.40 |
| 80305 |
|
563 |
243 |
$286.54 |
| J2704 |
Injection, propofol, 10 mg |
6,752 |
6,595 |
$284.14 |
| 84436 |
|
50 |
50 |
$262.20 |
| V5014 |
Repair/modification of a hearing aid |
13 |
13 |
$260.22 |
| 84681 |
|
12 |
12 |
$249.71 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,634 |
1,530 |
$216.65 |
| 86231 |
|
29 |
28 |
$198.75 |
| 86753 |
|
91 |
91 |
$197.25 |
| 80348 |
|
87 |
82 |
$196.96 |
| 87808 |
|
49 |
49 |
$193.80 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
404 |
401 |
$179.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
941 |
607 |
$179.44 |
| 82247 |
|
41 |
40 |
$176.98 |
| 84155 |
|
68 |
67 |
$174.68 |
| 96376 |
|
1,278 |
1,187 |
$170.84 |
| 87328 |
|
12 |
12 |
$152.00 |
| 82103 |
|
12 |
12 |
$148.56 |
| 86308 |
|
71 |
71 |
$146.44 |
| 99484 |
|
2,101 |
1,992 |
$146.26 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
581 |
572 |
$145.40 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,930 |
1,717 |
$140.88 |
| 82378 |
|
30 |
24 |
$139.11 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,349 |
1,255 |
$135.57 |
| 85732 |
|
25 |
25 |
$130.94 |
| 72072 |
|
12 |
12 |
$127.20 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,518 |
6,360 |
$126.32 |
| 88300 |
|
282 |
281 |
$118.40 |
| 73560 |
|
29 |
27 |
$117.19 |
| 76882 |
|
15 |
13 |
$112.96 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
6,791 |
6,625 |
$108.37 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,761 |
2,478 |
$101.36 |
| 85705 |
|
14 |
13 |
$96.60 |
| 85613 |
|
13 |
13 |
$94.10 |
| 86677 |
|
12 |
12 |
$89.20 |
| 86580 |
|
15 |
14 |
$82.50 |
| 86015 |
|
12 |
12 |
$78.02 |
| L1820 |
Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
15 |
15 |
$76.88 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,262 |
1,856 |
$75.90 |
| 80324 |
|
14 |
13 |
$72.28 |
| 80353 |
|
14 |
13 |
$72.28 |
| 80359 |
|
14 |
13 |
$72.28 |
| 80358 |
|
14 |
13 |
$72.28 |
| 80346 |
|
14 |
13 |
$72.28 |
| 80365 |
|
14 |
13 |
$72.28 |
| 80354 |
|
14 |
13 |
$72.28 |
| 80361 |
|
14 |
13 |
$72.28 |
| 98968 |
|
324 |
216 |
$70.00 |
| 73600 |
|
15 |
14 |
$69.80 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,156 |
8,531 |
$69.31 |
| 85670 |
|
13 |
13 |
$68.23 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
642 |
357 |
$68.08 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
25 |
25 |
$66.00 |
| 85652 |
|
42 |
42 |
$65.86 |
| 82310 |
|
15 |
12 |
$65.61 |
| 71100 |
|
12 |
12 |
$65.00 |
| 90461 |
|
56 |
56 |
$60.00 |
| 80143 |
|
569 |
557 |
$58.29 |
| 84075 |
|
12 |
12 |
$54.90 |
| 80179 |
|
503 |
493 |
$52.70 |
| 86431 |
|
12 |
12 |
$50.22 |
| 98967 |
|
115 |
98 |
$50.00 |
| 82248 |
|
14 |
14 |
$49.33 |
| 83721 |
|
23 |
23 |
$47.83 |
| 84520 |
|
13 |
13 |
$41.52 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,122 |
945 |
$40.52 |
| 96417 |
|
234 |
146 |
$38.61 |
| S0028 |
Injection, famotidine, 20 mg |
201 |
177 |
$36.03 |
| 73000 |
|
22 |
14 |
$33.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
982 |
887 |
$22.73 |
| 84132 |
|
13 |
12 |
$20.96 |
| L4361 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf |
166 |
165 |
$18.31 |
| J2060 |
Injection, lorazepam, 2 mg |
1,609 |
1,406 |
$13.35 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
140 |
139 |
$11.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
812 |
768 |
$10.70 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
118 |
117 |
$8.24 |
| 87071 |
|
25 |
24 |
$6.93 |
| J1630 |
Injection, haloperidol, up to 5 mg |
237 |
187 |
$4.85 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,010 |
836 |
$4.01 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
615 |
605 |
$2.64 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
177 |
159 |
$1.65 |
| C9113 |
Injection, pantoprazole sodium, per vial |
35 |
29 |
$1.05 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
32 |
32 |
$0.62 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
263 |
252 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
96 |
95 |
$0.00 |
| C1769 |
Guide wire |
110 |
108 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
65 |
64 |
$0.00 |
| 94760 |
|
17 |
13 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
14 |
14 |
$0.00 |
| V5264 |
Ear mold/insert, not disposable, any type |
42 |
41 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
24 |
12 |
$0.00 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
54 |
53 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
41 |
40 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
36 |
14 |
$0.00 |
| C1781 |
Mesh (implantable) |
13 |
12 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
48 |
38 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
56 |
46 |
$0.00 |
| 88302 |
|
42 |
42 |
$0.00 |
| 84145 |
|
84 |
79 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
234 |
233 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
12 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
26 |
14 |
$0.00 |
| 98966 |
|
30 |
24 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
28 |
24 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
16 |
15 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
25 |
25 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
46 |
42 |
$0.00 |